Here"s why a slowdown might mean more IPOs in tech, but fewer in biotech
The economic slowdown in the past couple of months could lead to long-term changes for Boston's innovation industry, giving some tech startups the chance to stay independent, while pushing biotech firms toward acquisitions......»»
The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs
Biotech stocks witnessed a slowdown in momentum last week, which was a relatively slow one in terms of news flow. Amgen, Inc. read more.....»»
IPO News This Week: Two Solid Offerings on Tap
The two IPOs on this week's calendar include one tech unicorn and a biotech working on a treatment from Alzheimer disease......»»
Microsoft co-founder Bill Gates reportedly sells home in Washington in fast deal
Tech billionaire Bill Gates now has one fewer home. He reached a deal earlier this month to sell a 2,430-square foot house he owned in Washington, according to Realtor.com......»»
Case Western Reserve launches startup incubator in Cleveland Innovation District
Case Western Reserve University has redeveloped the former BioEnterprise Inc. building in University Circle as a startup incubator for early-stage businesses in the biotech, health tech and engineering fields......»»
Will March Inflation Data Break Tech Rally"s Back? Why Wall Street"s "Dean Of Valuation" And Gene Munster Are Worried, But Paul Krugman And Other Economists Are Not
Economists generally predict a slight slowdown in the month-over-month inflation rate, with consumer prices and the core reading potentially rising by 0.3% in March compared to 0.4% in February. read more.....»»
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) read more.....»»
The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs
Biotech stocks reversed course in the week ended April 16, with the sector re.....»»
Top Ten: Weekend reads: The value proposition in the stock market
Also: tips for getting your $1,400 stimulus payment; biotech stocks picks; two IPOs and the next dominant electric-vehicle maker after Tesla......»»
Coupang Shows US Is Most Lucrative Market For Tech IPOs : Bloomberg
South Korean e-commerce major Coupang Inc.’s (NYSE: CPNG) IPO is slated to be the read more.....»»
: London set to overhaul listing rules to attract tech IPOs and cash in on blank-check boom
Government-backed review proposes allowing dual-class shares to give founders greater control of their businesses......»»
Nvidia Investors Are Pulling Back On Q4 Results, But These Analysts Still Like Chipmaker"s Potential
NVIDIA Corporation (NASDAQ: NVDA) reported better-than-expected quarterly results Wednesday, but the stock is slipping amid a sector-wide tech sell-off and concerns about a potential slowdown in .....»»
The Past Week"s Notable Insider Buys: More Biotech IPOs, Bumble, Fiserv And More
Insider buying can be an encouraging si.....»»
The Petri Dish: Thermo Fisher buys cell sorting tech, ProterixBio unveils antibody test
A biotech unveils a new Covid-19 antibody test, while Thermo Fisher buys a cell sorting technology firm. Here's The Petri Dish, a roundup of Greater Boston life sciences and health care happenings......»»
The Past Week"s Notable Insider Buys: Biotech IPOs, Curiositystream, Greenbrier And More
Insider buying ca.....»»
Khosla Ventures gets into the SPAC boom with plans to raise $1.2B in 3 IPOs
Another major Silicon Valley tech investor joins the record run of "blank check" IPOs. Menlo Park-based Khosla Ventures filed plans Friday to raise $1.2 billion for special purpose acquisition companies (SPACs) that aim to take three yet-to-be-dete.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vaccine updates, M&A activity, IPO news flow and follow-on offerings all served to lift stocks higher. read more.....»»
The Week Ahead In Biotech (Feb. 7-13): Regeneron FDA Decision, Earnings, IPOs and Conference Presentations In The Spotlight
Biopharma stocks advanced in the week ended Feb. 5, driven higher by a slew of catalysts. Large-cap pharma earnings, vac.....»»
Previewing This Week"s IPOs
This week has eight scheduled IPOs with three billion-dollar deals coming from the biotech, diagnostics, software and solar equipment industries, among others. Here's a rundown. read more.....»»
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 7) read more.....»»
IPO Report: IPOs in 2021: After a year of impressive pandemic offerings, these tech companies expect to keep it rolling
After an unbelievable 2020 for IPOs, with young technology companies and blank-check offerings leading to the biggest year for Wall Street debuts since the heyday of the dot-com boom, companies are lining up in hopes that 2021 is a worthwhile sequel......»»